NewsRoom Articles - Page 35 of 231

ThursdayMar 13, 2025 10:00 am

Why it is Crucial to Prepare Healthcare Data for Use in AI Models

The rate at which AI is being integrated in healthcare is accelerating. However, data quality is often lacking, and this reduces the effectiveness of many AI solutions tailored to the healthcare industry. Given that healthcare data is often siloed, the vast majority of this data is unstructured. This can pose challenges in the use of this data for AI models since the insights extracted could be biased or have other defects. Data needs to be consistent in the way it is presented, its quality must be high and the formats need to be standardized. Otherwise, the data could be misinterpreted…

ThursdayMar 13, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’

Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals. The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications. Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives. The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease. Soligenix is led by an experienced management team with a strong track record of success. Soligenix (NASDAQ:…

WednesdayMar 12, 2025 9:00 am

Clene Inc. (NASDAQ: CLNN) to Present CNM-Au8(R) Updates at 37th Annual Roth Conference

The 37th Annual Roth Conference, to be held March 16-18 in Dana Point, California, will showcase the broadest group of companies in the event’s history, with senior executives from approximately 500 companies across various industries, including business services, consumer, healthcare, insurance, sustainability and technology, media and entertainment. Clene’s management will participate in a virtual fireside chat at 9:20 a.m. PST on March 18, as well as one-on-one investor meetings during the event. During the fireside chat and in investor meetings, the company will detail recent achievements and next steps for lead drug candidate CNM-Au8 for ALS and MS. Clene Inc.…

TuesdayMar 11, 2025 10:00 am

Study Finds Experimental Drug Prolongs the Survival of Glioblastoma Patients

A recent study whose findings appeared in the Nature Communications journal has shown that a new experimental drug can increase the survival time of patients who have been diagnosed with glioblastoma. This brain cancer is the most prevalent brain cancer in adults. The experimental drug, dubbed 186RNL (Rhenium Obisbemeda), was developed at UT Health San Diego. The trial established that this drug candidate, at the very least, doubled the progression-free and survival duration of study participants in comparison to the known progression-free or survival rates of patients afflicted by this brain tumor. It also didn’t have any side effects that…

FridayMar 07, 2025 10:00 am

Bacterial Imbalances Have a Link to Multiple Sclerosis, Study Finds

Approximately a million Americans suffer from multiple sclerosis (MS), and globally, more than 2.8 million individuals have this condition. Several factors are thought to play a role in the development of this autoimmune condition, such as genetics, environmental factors, infectious disease, diet, and gut health. A new study has shown that imbalances in certain types of gut bacteria not only strongly indicate the likelihood of this illness developing but could also be a pointer to the severity of the disease in affected individuals. The researchers discovered that the ratio of two specific bacteria in the gut was a strong predictor…

FridayMar 07, 2025 10:00 am

Adageis Secures $2M Seed Funding to Expand AI-Driven Healthcare Solutions

Adageis closed a $2 million seed round at the end of Q4 2024 to support operational expansion, with the funding to enhance backend operations for next-generation software upgrades. Upgraded Electronic Health Record EHR”) connectivity will facilitate integration with over 90 EHR systems, while increased sales force investment will help accelerate growth and market adoption. Adageis’ AI-powered platform is designed to streamline healthcare operations, optimize provider revenue, and improve patient care outcomes. Adageis, a forward-thinking healthcare technology company reshaping patient care through flexible AI-centric software solutions for healthcare organizations, has secured $2 million in seed financing to enhance its operations and…

ThursdayMar 06, 2025 10:00 am

Why it is Important to Ensure the Stability of Medicare Advantage

About 34 million Americans are enrolled in Medicare Advantage plans and these older people as well as people with disabilities depend on these plans to get access to quality healthcare at an affordable cost. MA plans offer additional coverage, such as dental care, preventive screenings, transportation assistance and other such care that is critical for maintaining the health of these seniors. Recently, the CMS approved a 4.33 percent increase in the payment for MA plans with effect from 2026. This increase means approximately $21 billion will be added to the funds available to support MA plans, something that will go…

WednesdayMar 05, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Pioneers Systemic Virotherapy with RTNova Platform

Calidi’s RTNova platform leverages engineered enveloped vaccinia viruses designed for systemic delivery. Calidi’s groundbreaking virotherapy holds “immense promise in revolutionizing the treatment landscape for cancer patients with advanced solid tumors,” says CEO. Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of developing innovative immunotherapies for cancer treatment. Most recently, the company has captured the spotlight for the development of its proprietary systemic platform, RTNova (https://ibn.fm/Z4pM3). The platform represents a significant advancement in systemic virotherapy, particularly in the utilization of enveloped virotherapies to target metastatic tumors across the body. Antitumor virotherapy employs viruses that selectively infect and…

WednesdayMar 05, 2025 10:45 am

Clene Inc. (NASDAQ: CLNN) to Highlight Latest Achievements, Next Steps for CNM-Au8(R), at Q1 Virtual Investor Summit on March 11

The Q1 Virtual Investor Summit will focus on microcap companies that are undervalued, and aim to create connections between leading investors and microcap companies Clene’s presentation will be given by CEO Rob Etherington and CFO Morgan Brown Clene’s participation in the event comes as the company is moving closer to submitting a New Drug Application to the FDA to secure potential accelerated approval for CNM-Au8® for ALS The company recently partnered with German-based APST Research GmbH to analyze neurofilament light chain (“NfL”) data for evaluating CNM-Au8 efficacy in ALS patients. Clene Inc. (NASDAQ: CLNN) and its wholly owned subsidiary, Clene…

TuesdayMar 04, 2025 10:00 am

Scientists Say Brain Stimulations Hold Potential in Treating Anxiety in Parkinson’s Sufferers

Researchers studying brain waves have suggested that a new discovery they have made could hold the key to treating anxiety in people diagnosed with Parkinson’s disease. For a long time, DBS (deep brain stimulation) has been leveraged in the management of the physical symptoms linked to Parkinson’s, such as tremor, slowness and body stiffness. This new research suggests that DBS can take advantage of a specific brain wave and help treat anxiety in those with Parkinson’s disease. Doctor Lucia Ricciardi, who co-led the study and works at University of London, explained that anxiety is a serious unmet medical need among…